RAD51C and ovarian cancer: In addition, analysis of the promoters of BRCA1 and RAD51C, whose methylation has been shown to be associated with HRD in breast and ovarian cancer [51], revealed that UCS10 and UCS12 displayed RAD51C promoter hypermethylation.